Imaging of repeated episodes of demyelination and remyelination in multiple sclerosis

Robert A Brown1, Sridar Narayanan1, Douglas L Arnold1

  • 1McConnell Brain Imaging Centre, Montreal Neurological Institute and Hospital, 3801 Rue University, Montreal H3A 2B4, Canada.

Neuroimage. Clinical
|January 23, 2015
PubMed

Insights

Multiple sclerosis (MS) lesions evolve over time, with new lesions forming in normal-appearing white matter (WM) and repeat lesions occurring in previously affected areas. Both types show incomplete recovery, suggesting partial remyelination in MS.

Area of Science:

  • Neuroscience
  • Radiology
  • Immunology

Background:

  • Multiple sclerosis (MS) involves demyelination in the brain's white matter (WM).
  • The precise timeline of white matter lesion development in MS remains unclear.
  • Understanding lesion evolution is crucial for developing effective MS therapies.

Purpose of the Study:

  • To investigate the temporal dynamics of white matter lesion formation and evolution in MS.
  • To characterize the process of demyelination and remyelination using magnetization transfer ratio (MTR) imaging.
  • To differentiate between new (de novo) and recurrent (repeat) lesions in MS patients.

Main Methods:

  • Utilized a novel technique to analyze MTR timecourses in segmented white matter lesions.
  • Examined MTR data from patients with relapsing-remitting MS (RRMS) and secondary progressive MS (SPMS).
  • Identified and tracked both de novo and repeat lesions over time.

Main Results:

  • Observed MTR lesions forming in previously normal-appearing white matter (de novo lesions).
  • Detected repeat lesions in areas previously affected by demyelination, indicating recurrent inflammatory activity.
  • Both de novo and repeat lesions demonstrated significant, albeit incomplete, MTR recovery, suggesting partial remyelination.
  • Post-lesion MTR values in de novo lesions were comparable to pre-lesion values in repeat lesions.
  • Repeat lesions were more prevalent in the secondary progressive MS phase.

Conclusions:

  • MS lesions result from multiple episodes of demyelination and incomplete remyelination.
  • The findings support a model of lesion development involving repeated inflammatory attacks and partial repair.
  • These insights have potential implications for neuroprotective and remyelination-enhancing therapeutic strategies in MS.